Hosey et al. (2007) suggested that breast cancer patients with BRCA2Mut were unlikely to be ER-deficient because of the ability of estrogen metabolites to induce loss of the second BRCA1 allele, thus, estrogen may somehow facilitate the survival of BRCA1-deficient cells in hormonally responsive tissues. This evidence concerns the gene ESR1 and breast cancer.